< Back to Search

Neurology® Neuroimmunology & Neuroinflammation Podcast - October 2014 Issue

Treatment resistant immune thrombocytopenic purpura

Ransohoff, Editor of Neurology: Neuroimmunology & Neuroinfammation introduces the podcast initiative and the following interview. Dr. Scott Zamvil then interviews Dr. Oivind Torkildsen about his paper on treatment resistant immune thrombocytopenic purpura associated with low-dose naltrezone use in a patient with MS. Richard M. Ransohoff conducts research supported by the NIH, the National MS Society, the DOD, the Alzheimer's Association, the Guthy-Jackson Foundation, Williams Family Foundation for MS Research, ChemoCentryx, Lundbeck, Teva, Novartis, Genzyme, and Biogen-Idec. Dr. Ransohoff has received fees for preclinical consul Read More

Download this Episode

Episode Segments


00:17 01:51

Play Segment

Interview: Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS


10:53 11:50

Play Segment



Email pbaskin@neurology.org

Neurology® Neuroimmunology & Neuroinflammation Podcast

View Full List of Podcast Episodes

Search Episodes

Browse Episodes